- Abscess
- Aspergillosis
- Bacterial infections
- Blastomycosis
- Cellulitis
- Clostridium difficile infection
- COVID-19 virus disease
- Encephalitis
- Epstein-Barr virus (EBV)
- Fever of unknown origin
- Flu (influenza)
- Fungal infection
- Helicobacter pylori (H. Pylori)
- Histoplasmosis
- Infectious complications with solid tumor
- Infectious disease
- Latent tuberculosis (LTBI)
- Lyme disease
- Lymphadenopathy (Enlarged lymph nodes)
- Meningitis
- Methicillin resistant staphylococcus aureus (MRSA)
- Parasitic infections
- Pneumonia
- Positive QuantiFERON gold test result
- Pulmonary tuberculosis (TB)
- Shingles
- Skin infections
- Skin rash
- Staphylococcal infections
- Travel-associated infection
- Traveler's diarrhea
- Tropical medicine
- Urinary tract infection
- Viral infectious disorders
- Wound infection
Harvey Rubin, MD, PhD
Infectious Diseases
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program
Penn Medicine Provider
About me
- Professor of Medicine (Infectious Diseases)
&Dr. Rubin is a Professor of Medicine at the University of Pennsylvania with secondary appointments as Professor in the Department of Biochemistry and Biophysics, and as Professor of Computer and Information Sciences at the University of Pennsylvania School of Engineering and Applied Sciences. His research in infectious diseases has been funded by the NIH, NSF, DARPA, the Global Alliance for TB Drug Discovery, and the Department of Defense. In addition to his work on the basic biology of bacterial pathogenesis, he has extended the investigations to mathematical modeling of complex biological systems. His research has resulted in more than 100 peer-reviewed papers chapters or reviews. His clinical practice is limited to infectious diseases and he sees patients at the Hospital of the University of Pennsylvania.
Dr. Rubin has served on a number of national and international scientific review panels including the NIH, NSF, NASA Intelligent Systems Program, DARPA, and The Medical Research Council, South Africa. He was a member of the United States National Science Advisory Board for Biosecurity (NSABB), and the Department of Defense/National Academy of Sciences Biological Cooperative Threat Reduction Program. He has published and lectured extensively on policy issues that relate to infectious diseases.
Dr. Rubin is the founder of Energize the Chain, a non-profit organization that ensures the delivery of vaccines to people in the most remote regions of the world by utilizing power and connectivity in the private sector, such as that available at cell tower sites to power the refrigeration systems that are necessary to keep vaccines at the proper temperature.
My education and training
- Medical School: Columbia University
- Residency: Mass General Brigham Healthcare Center - Chestnut Hill
Spoken languages
English
English
Reviews
71 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
- Penn Medicine Rittenhouse Long-Term Acute Care Hospital: Has privileges to treat patients in the hospital.
Qualifications and experience
- Internal Medicine, 1979
- Department of Defense, National
- Energize the Chain, International
- Franklin Institute, Local
- Global Alliance for TB Drug Development-Development of new anti TB agents:=, International
- Incentives for Global Health Impact Fund, International
- International Center for the Study of Radicalisation and Political Terrorism, International
- Interurban Clinical Club, Local
- John Morgan Society, Local
- John Scott Award Selection Committee, National
- Leiden Center for Natural Computing, University of Leiden, The Netherlands, International
- Natural Computing Series, Springer-Verlag Press, National
- NIAID, National
- NIH, National
- NIH ACTG, National
- The College of Physicians of Philadelphia, Local
Treatments and conditions
Research
Publications
Abhiraman B, Fotis R, Eskin L, Rubin H. Fault Detection for Vaccine Refrigeration via Convolutional Neural Networks Trained on Simulated Datasets. , International Journal of Refrigeration. Volume 149, May 2023, Pages 274-285.: 2023
Kim .J, Xin Chen X, Nikpey. H, Rubin. H, Bidokhti SS, Sarkar S. Tracing and testing multiple generations of contacts to COVID-19 cases: cost-benefit trade-offs. , R Soc Open Sci . 2022 Oct 12;9(10):211927. doi: 10.1098/rsos.211927. eCollection 2022 Oct.: 2022
Chowdhury SR, Rafayat S, Yasir MT, Hossain S, Shetty S, Tahsin S, Rubin H, Rahaman A. Vaccine Storage and Distribution in Rural Bangladesh. , International Journal of Medicine and Public Health,2022,12,2,56-64. DOI:10.5530/ijmedph.2022.2.12.: 2022
Ali RN, Rubin H, Sarkar S Countering the potential re-emergence of a deadly infectious disease—Information warfare, identifying strategic threats, launching countermeasures.: , PLoS ONE 16(8): 2021
Dutta NK, Klinkenberg LG, Vazquez M-J, Segura-Carro D, Colmenarejo G, Ramon F, Rodriguez-Miquel B, Mata-Cantero L, Porras-De Francisco E, Chuang Y-M, Rubin H, Lee JJ, Eoh H, Bader JS, Perez-Herran E, Mendoza-Losana A, Karakousis PC Inhibiting the stringent response blocks entry into quiescence and reduces persistence , Science advances, 5(3): 2019,eaav2104
Harbut MB, Yang B, Liu R, Yano T, Vilchèze C, Cheng B, Lockner J, Guo H, Yu C, Franzblau SG, Petrassi HM, Jacobs WR, Rubin H, Chatterjee AK, Wang F Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity , Angewandte Chemie (International ed. in English), 57(13): 2018,3478-3482
Ogura M, Wakaiki M, Rubin H, Preciado VM Delayed bet-hedging resilience strategies under environmental fluctuations , Physical Review E, 95(5-1): 2017,052404
Tantry SJ, Markad SD, Shinde V, Bhat J, Balakrishnan G, Gupta AK, Ambady A, Raichurkar A, Kedari C, Sharma S, Mudugal NV, Narayan A, Naveen KCN, Nanduri R, Bharath S, Reddy J, Panduga V, Prabhakar KR, Kandaswamy K, Saralaya R, Kaur P, Dinesh N, Guptha S, Rich K, Murray D, Plant H, Preston M, Ashton H, Plant D, Walsh J, Alcock P, Naylor K, Collier M, Whiteaker J, McLaughlin RE, Mallya M, Panda M, Rudrapatna S, Ramachandran V, Shandil R, Sambandamurthy VK, Mdluli K, Cooper CB, Rubin H, Yano T, Iyer P, Narayanan S, Kavanagh S, Mukherjee K, Balasubramanian V, Hosagrahara VP, Solapure S, Ravishankar S, Hameed PS Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis , J Med Chem, 60(4): 2017,1379-1399
Chuang YM, Dutta NK, Hung CF, Wu TC, Rubin H, Karakousis PC The stringent response factors PPX1 and PPK2 play an important role in Mycobacterium tuberculosis metabolism, biofilm formation, and sensitivity to isoniazid in vivo , Antimicrob Agents Chemother: 2016,pii: AAC.01139-16.
Chuang YM, Bandyopadhyay N, Rifat D, Rubin H, Bader JS, Karakousis PC. Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis , MBio, 6(2): 2015,e02428